샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777729

급성 세균성 피부 및 피부 구조 감염 시장

Acute Bacterial Skin and Skin Structure Infections
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 355 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

급성 세균성 피부 및 피부 구조 감염 세계 시장은 2030년까지 15억 달러에 이를 전망

2024년에 13억 달러로 추정되는 급성 세균성 피부 및 피부 구조 감염 세계 시장은 2024-2030년의 분석 기간에 CAGR 2.7%로 성장하여 2030년에는 15억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 커뮤니티 감염형 ABSSI는 CAGR 2.5%를 나타내고, 분석 기간 종료까지 12억 달러에 이를 것으로 예측됩니다. 병원 후천성 ABSSI 분야의 성장률은 분석 기간중 CAGR 4.0%로 추정됩니다.

미국 시장은 3억 4,980만 달러로 추정, 중국은 CAGR 5.2%로 성장 예측

미국의 급성 세균성 피부 및 피부 구조 감염 시장은 2024년에 3억 4,980만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년 CAGR5.2%로 성장을 지속하여 2030년까지 2억 9,150만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.0%와 2.1%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 1.5%를 나타낼 전망입니다.

세계의 급성 세균성 피부 및 피부 구조 감염 시장 - 주요 동향과 촉진요인 정리

ABSSSI란 무엇이며, 왜 현대 헬스케어에서 ABSSSI의 관리가 중요한가?

급성 세균성 피부 및 피부 구조 감염에는 봉와직염, 농양, 상처 감염과 같은 심각한 세균 감염이 광범위하게 포함됩니다. 이러한 병태는 메티실린 내성균(MRSA)을 포함한 황색포도상구균, 화농성 연쇄상구균 등의 병원균에 기인하는 경우가 많으며, 효과적인 치료에 큰 어려움이 있습니다. ABSSSI의 관리는 전 세계 인구의 고령화, 당뇨병 유병률 증가, 수술 건수 증가 등의 요인으로 인해 유병률이 증가하고 있기 때문에 매우 중요하게 여겨지고 있습니다. 이러한 감염은 신속하게 치료하지 않으면 패혈증, 입원 기간 연장 등 심각한 합병증을 유발하여 전 세계 의료 시스템에 큰 부담을 줄 수 있습니다. ABSSSI 대응을 위해 표적 치료제와 첨단 항생제 개발이 필수적이며, 환자의 빠르고 효과적인 회복을 보장하면서 항균제 내성에 대응할 수 있는 솔루션을 제공합니다.

항생제 치료의 혁신은 ABSSSI 치료에 어떤 혁명을 가져오고 있는가?

ABSSSI 치료 현장에서는 효과와 환자 예후를 개선하기 위한 차세대 항생제 및 새로운 전달 시스템 개발로 인해 상당한 기술 혁신이 일어나고 있습니다. 반코마이신이나 뎁토마이신과 같은 전통적인 항생제는 여전히 널리 사용되고 있지만, 내성 균주의 출현으로 인해 첨단 대체 약물의 도입이 필요하게 되었습니다. tedizolid, dalbavancin, oritavancin과 같은 새로운 약물은 내성 병원체에 대한 활성을 높이고, 투여 횟수를 줄이며, 부작용을 줄임으로써 유망한 결과를 보여주고 있습니다. 또한, 병용요법은 서로 다른 박테리아 메커니즘을 표적으로 삼아 다제내성균을 퇴치하는 효과적인 전략으로 부상하고 있습니다. 지속형 제제, 주사제 항생제 등 약물 전달의 혁신으로 환자의 순응도가 향상되고 입원 횟수가 감소했습니다. 또한, 신속한 진단 도구의 발전으로 병원균의 조기 식별이 용이해져 맞춤 치료 접근이 가능해졌고, 광범위 항생제의 과다 사용을 최소화할 수 있게 되었습니다. 이러한 개발로 인해 ABSSSI 환자의 표준 치료가 크게 향상되었습니다.

시장 수요를 주도하는 지역과 환자층은?

ABSSSI 치료에 대한 수요는 지역마다 크게 다르며, 의료 접근성, 내성 병원균의 확산, 질병에 대한 인식의 차이에 따라 형성됩니다. 북미와 유럽은 ABSSSI 치료의 주요 시장으로, 높은 의료 인프라, 높은 진단율, 항균제 스튜어드십에 대한 높은 관심이 그 원동력이 되고 있습니다. 이들 지역에서는 병원 내 감염과 수술 부위 감염의 발생률이 증가하고 있어 새로운 항생제 및 표적치료제 도입에 더욱 박차를 가하고 있습니다. 한편, 아시아태평양은 인구 증가, 의료비 증가, 감염성 질환의 확산으로 인해 주요 성장 시장으로 부상하고 있습니다. 특히 중국이나 인도와 같은 국가들은 의료 인프라가 확장되고 항생제 내성 문제에 대한 인식이 높아지면서 항생제 내성에 대한 인식이 높아지는 추세입니다. 환자층에서는 당뇨병, HIV 감염자, 화학요법 중인 환자 등 면역력이 저하된 환자가 시장 수요의 대부분을 차지하고 있습니다. 또한, 인구 고령화와 만성 상처 및 욕창 환자 증가는 전 세계적으로 ABSSSI의 확산에 기여하고 있습니다.

ABSSSI 시장의 성장을 가속하는 요인은 무엇인가?

급성 세균성 피부-피부 구조물 감염시장이러한 성장은 약제 내성 병원균 증가, 항생제 개발의 발전, 감염 관리에 대한 인식 증가 등 여러 요인에 의해 발생합니다. MRSA와 같은 내성균 증가는 기존 항생제의 한계를 극복할 수 있는 혁신적인 치료법에 대한 수요를 증가시키고 있습니다. 새로운 항생제 및 병용요법을 포함한 표적 치료의 발전은 어려운 감염 질환에 대한 효과적인 해결책을 제공합니다. ABSSSI에 걸리기 쉬운 당뇨병과 같은 만성질환 증가도 시장 성장에 박차를 가하고 있습니다. 신흥 시장에서의 의료 서비스 접근성 확대와 항균제 내성 퇴치를 위한 정부의 이니셔티브는 첨단 치료 솔루션의 채택을 더욱 촉진하고 있습니다. 또한, 제약사들의 연구개발 투자와 신속한 진단 도구의 도입으로 조기 발견과 치료 효과가 향상되어 ABSSSI 세계 시장의 지속적인 성장이 보장되고 있습니다.

부문

감염 유형(커뮤니티 감염형 ABSSI, 원내 감염형 ABSSI), 투여 경로(경구 투여, 비경구 투여, 국소 투여), 유통 채널(병원 약국 유통 채널, 소매 약국 유통 채널, 온라인 약국 유통 채널)

조사 대상 기업 예

  • AbbVie, Inc.
  • Basilea Pharmaceutica Ltd.
  • Cipher Pharmaceuticals Inc.
  • Cumberland Pharmaceuticals Inc.
  • Melinta Therapeutics LLC
  • MicuRx Pharmaceuticals, Inc.
  • Nabriva Therapeutics plc
  • Paladin Labs Inc.
  • Paratek Pharmaceuticals, Inc.
  • Recce Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.

AI 통합

검증된 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁합니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.06

Global Acute Bacterial Skin and Skin Structure Infections Market to Reach US$1.5 Billion by 2030

The global market for Acute Bacterial Skin and Skin Structure Infections estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 2.7% over the analysis period 2024-2030. Community-Acquired ABSSI, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Hospital- Acquired ABSSI segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$349.8 Million While China is Forecast to Grow at 5.2% CAGR

The Acute Bacterial Skin and Skin Structure Infections market in the U.S. is estimated at US$349.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$291.5 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Acute Bacterial Skin and Skin Structure Infections Market - Key Trends & Drivers Summarized

What Are ABSSSIs, and Why Is Their Management Crucial in Modern Healthcare?

Acute bacterial skin and skin structure infections encompass a broad spectrum of serious bacterial infections, including cellulitis, abscesses, and wound infections. These conditions often result from pathogens such as Staphylococcus aureus, including its methicillin-resistant strain (MRSA), and Streptococcus pyogenes, posing significant challenges for effective treatment. The management of ABSSSIs has gained critical importance due to their rising prevalence, driven by factors such as an aging global population, the increasing prevalence of diabetes, and the growing number of surgical procedures. These infections, if not treated promptly, can lead to severe complications, including sepsis and prolonged hospital stays, placing a significant burden on healthcare systems worldwide. The development of targeted therapies and advanced antibiotics has become essential in combating ABSSSIs, offering solutions that address antimicrobial resistance while ensuring rapid and effective patient recovery.

How Are Innovations in Antibiotic Therapies Revolutionizing ABSSSI Treatment?

The treatment landscape for ABSSSIs has witnessed substantial innovation, with the development of new-generation antibiotics and novel delivery systems aimed at improving efficacy and patient outcomes. Traditional antibiotics such as vancomycin and daptomycin continue to be widely used; however, the emergence of resistant strains has necessitated the introduction of advanced alternatives. Novel agents like tedizolid, dalbavancin, and oritavancin have shown promising results, offering enhanced activity against resistant pathogens, reduced dosing frequency, and fewer side effects. Additionally, combination therapies have emerged as effective strategies to combat multi-drug-resistant organisms by targeting different bacterial mechanisms. Innovations in drug delivery, such as long-acting formulations and injectable antibiotics, have improved patient compliance and reduced hospital admissions. Moreover, advancements in rapid diagnostic tools have facilitated the early identification of pathogens, enabling personalized treatment approaches and minimizing the overuse of broad-spectrum antibiotics. These developments are significantly enhancing the standard of care for ABSSSI patients.

Which Regions and Patient Demographics Are Driving Market Demand?

The demand for ABSSSI treatments varies significantly across regions, shaped by differences in healthcare access, prevalence of resistant pathogens, and disease awareness. North America and Europe are leading markets for ABSSSI therapies, driven by advanced healthcare infrastructure, high diagnostic rates, and a strong focus on antimicrobial stewardship. The growing incidence of hospital-acquired infections and surgical site infections in these regions has further fueled the adoption of novel antibiotics and targeted therapies. The Asia-Pacific region, however, is emerging as a key growth market due to its large population base, rising healthcare expenditures, and increasing prevalence of infectious diseases. Countries like China and India are particularly prominent, with expanding healthcare infrastructures and heightened awareness of antibiotic resistance challenges. Within patient demographics, individuals with compromised immune systems, such as those with diabetes, HIV, or undergoing chemotherapy, represent a significant portion of the market demand. Additionally, the aging population and the growing number of patients with chronic wounds and pressure ulcers are contributing to the increased prevalence of ABSSSIs worldwide.

What Factors Are Driving Growth in the ABSSSI Market?

The growth in the Acute Bacterial Skin and Skin Structure Infections market is driven by several factors, including the increasing prevalence of drug-resistant pathogens, advancements in antibiotic development, and growing awareness of infectious disease management. The rise of resistant strains such as MRSA has heightened the demand for innovative therapies that address the limitations of traditional antibiotics. Advances in targeted therapies, including new antibiotics and combination treatments, have provided effective solutions to combat challenging infections. The increasing prevalence of chronic conditions such as diabetes, which predispose individuals to ABSSSIs, has also fueled market growth. Expanding healthcare access in emerging markets, combined with government initiatives to combat antimicrobial resistance, has further supported the adoption of advanced treatment solutions. Additionally, investments in R&D by pharmaceutical companies and the introduction of faster diagnostic tools have enhanced early detection and treatment efficacy, ensuring sustained growth in the global ABSSSI market.

SCOPE OF STUDY:

The report analyzes the Acute Bacterial Skin and Skin Structure Infections market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Infection Type (Community-Acquired ABSSI, Hospital- Acquired ABSSI); Route of Administration (Oral Administration, Parenteral Administration, Topical Administration); Distribution Channel (Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 25 Featured) -

  • AbbVie, Inc.
  • Basilea Pharmaceutica Ltd.
  • Cipher Pharmaceuticals Inc.
  • Cumberland Pharmaceuticals Inc.
  • Melinta Therapeutics LLC
  • MicuRx Pharmaceuticals, Inc.
  • Nabriva Therapeutics plc
  • Paladin Labs Inc.
  • Paratek Pharmaceuticals, Inc.
  • Recce Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Acute Bacterial Skin and Skin Structure Infections - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Complicated SSTIs Drives Demand for Broad-Spectrum Antibacterial Therapeutics
    • Expansion of Outpatient Parenteral Antibiotic Therapy Throws the Spotlight on Long-Acting IV Antibiotics
    • Increased Prevalence of MRSA and Drug-Resistant Pathogens Spurs Innovation in Novel Antibacterial Agents
    • OEM Focus on Once-Daily and Dual-Action Therapies Strengthens Patient Adherence and Treatment Efficiency
    • Regulatory Fast-Track and Priority Review Pathways Accelerate Launch of First-in-Class SSTI Drugs
    • Growing Clinical Preference for IV-to-Oral Switch Therapies Expands Use of Oral Agents in Moderate Infections
    • Integration of Rapid Diagnostic Tools Enhances Early Pathogen Identification and Antibiotic Stewardship
    • Hospital-Acquired SSTI Risk Reduction Protocols Drive Demand for Evidence-Based Treatment Algorithms
    • Emergence of Biosimilars and Non-Beta-Lactam Alternatives Expands Formulary Choices in Resistant Cases
    • Surge in Emergency Department Presentations for SSTIs Spurs Need for Immediate-Acting Therapeutics
    • OEM Development of Narrow-Spectrum Antibiotics Reduces Collateral Damage to Microbiome
    • Rising Incidence of Post-Surgical and Device-Related SSTIs Propels Hospital-Initiated Antibiotic Protocols
    • Global Antimicrobial Resistance Mitigation Programs Encourage Use of Targeted SSTI Regimens
    • Growth in Diabetic and Immunocompromised Populations Strengthens Demand for Fast-Acting Antibiotic Coverage
    • Use of Real-World Data From Electronic Medical Records Enhances Drug Effectiveness Analysis
    • Availability of Once-Weekly and Depot Antibiotic Therapies Supports Outpatient Management Models
    • Increasing Investment in Dual-Pathogen Trials and Multi-Organism Coverage Expands Drug Utility
    • Health System Push for Cost Containment and Shorter Hospital Stays Drives Oral Antibiotic Adoption
    • Surge in SSTI-Related Hospitalizations in Emerging Markets Propels Access to Advanced Therapeutics
    • Public and Professional Awareness Campaigns Support Early Recognition and Prompt Antibiotic Intervention
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Acute Bacterial Skin and Skin Structure Infections Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Community-Acquired ABSSI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Community-Acquired ABSSI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Community-Acquired ABSSI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hospital- Acquired ABSSI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hospital- Acquired ABSSI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hospital- Acquired ABSSI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Topical Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Online Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • JAPAN
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • CHINA
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • EUROPE
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • FRANCE
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • GERMANY
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • INDIA
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • AFRICA
    • Acute Bacterial Skin and Skin Structure Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Community-Acquired ABSSI and Hospital- Acquired ABSSI Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Infection Type - Percentage Breakdown of Value Sales for Community-Acquired ABSSI and Hospital- Acquired ABSSI for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Oral Administration, Parenteral Administration and Topical Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Topical Administration for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Acute Bacterial Skin and Skin Structure Infections by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제